Serveur d'exploration sur l'Indium - Curation (Accueil)

Index « MedMesh.i » - entrée « Organ Specificity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Organ Sparing Treatments < Organ Specificity < Organ Transplantation  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 65.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000499 (2013) Synthesis and in vitro and in vivo evaluation of hypoxia-enhanced 111In-bombesin conjugates for prostate cancer imaging.
000900 (2012) Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
000B31 (2013) Assessment of effective absorbed dose of (111)In-DTPA-Buserelin in human on the basis of biodistribution rat data.
001925 (2010) Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides.
001C22 (2010) Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging.
001D12 (2010) Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.
001F74 (2009) MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan.
002489 (2008) Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates.
002625 (2008) Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
002760 (2007) Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors.
002846 (2007) In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
002863 (2007) [(111)In]Pentetreotide SPECT scintigraphy in neuroendocrine tumors: variability of reconstructing parameters related to patient characteristics and each body part.
002921 (2007) Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
002A47 (2006) Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.
002A66 (2007) Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.
002A80 (2006) Comparison of conventional, model-based quantitative planar, and quantitative SPECT image processing methods for organ activity estimation using In-111 agents.
002B23 (2006) A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments.
002B41 (2006) Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.
002C32 (2006) Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.
002C33 (2006) Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.
002C81 (2006) Anticancer activity of targeted proapoptotic peptides.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Organ Specificity" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Organ Specificity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Organ Specificity
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024